DENTSPLY SIRONA Inc.

Valuation Analysis

About the Company

DENTSPLY SIRONA Inc. en bref

DENTSPLY SIRONA Inc. (XRAY) is currently trading at 9,01 € with a market capitalization of 1,8 Md €. The 52-week range spans from 8,20 € to 14,90 €; the current price is 39.6% below the yearly high. Year-over-year revenue growth stands at +0.1%.

💰 Dividende

DENTSPLY SIRONA Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

15 analystes évaluent DENTSPLY SIRONA Inc. (XRAY) au consensus : Conserver. L'objectif de cours moyen est de 11,68 €, soit un potentiel de +29.72% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 7,85 € à 14,82 €.

DENTSPLY SIRONA Inc. : la thèse d'investissement en détail

DENTSPLY SIRONA Inc. (XRAY) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue growth has slowed to just 0.1%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 12.18% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

With a PEG ratio of 0.74, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 7.64x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 29.72% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (12.18%), higher leverage relative to equity.

Trading Data

Related Stocks in the Same Sector

Where can I buy DENTSPLY SIRONA Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.